11 November 2019

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

11 November 2019 | n=28

  1. Breton G, Laborde-Balen G, Guilavogui F, Karemangino S, et al.
    HIV viral load algorithm, what are the needs in the field?
    AIDS 2019.

  2. Meyers T, Samson P, Acosta EP, Moye J, et al.
    Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
    AIDS 2019;33:2197-2203.

  3. Thornhill JP, Lynch KD, Skelton JK, Dorner M, et al.
    Vedolizumab use and the associations between alpha4beta7 expression and HIV reservoir in the gut during treated primary HIV infection.
    AIDS 2019;33:2268-2271.

  4. Duarte F, Soares MA.
    Simplified two-drug antiretroviral HIV treatment: novel data and expected impact.
    AIDS 2019;33:2266-2268.

  5. Tsukamoto T.
    Spontaneous HIV controllers might be the key to prevent accelerated immunosenescence of effector CD8+ T cells.
    AIDS 2019;33:2253-2255.

  6. Williams DW, Elahi S.
    Profound immune consequences for young adults infected with HIV perinatally or during childhood: a cautionary tale regarding adherence to antiretroviral therapy.
    AIDS 2019;33:2251-2252.

  7. Umlauf A, Soontornniyomkij B, Sundermann EE, Gouaux B, et al.
    Risk of developing cerebral beta-amyloid plaques with posttranslational modification among HIV-infected adults.
    AIDS 2019;33:2157-2166.

  8. Henriquez S, Lecuroux C, Bitu M, Avettand-Fenoel V, et al.
    The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients.
    AIDS 2019;33:2137-2147.

  9. Underwood ML, Nguyen T, Uebelhoer LS, Kunkel LE, et al.
    Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder.
    AIDS 2019.

  10. Calkins K, Chander G, Joshu C, Visvanathan K, et al.
    Differences in five year survival after cancer diagnosis between HIV clinic enrollees and the general US population.
    AIDS Res Hum Retroviruses 2019.

  11. Balzer LB, Havlir DV, Kamya MR, Chamie G, et al.
    Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda.
    Clin Infect Dis 2019.

  12. Krakower DS, Marcus JL.
    Machine learning for HIV prevention in rural Africa: the SEARCH for sustainability.
    Clin Infect Dis 2019.

  13. Li J, Armon C, Palella FJ, Novak RM, et al.
    Chlamydia and Gonorrhea Incidence and Testing among Patients in the HIV Outpatient Study, 2007-2017.
    Clin Infect Dis 2019.

  14. Mpoza E, Rajasingham R, Tugume L, Rhein J, et al.
    Cryptococcal Antigenemia in HIV therapy-experienced Ugandans with Virologic Failure.
    Clin Infect Dis 2019.

  15. Hoenigl M, Little SJ, Grelotti D, Skaathun B, et al.
    GrindrTM Users Take more Risks, but are more Open to HIV Pre-Exposure Prophylaxis: Could this Dating App Provide Platform for HIV Prevention Outreach?
    Clin Infect Dis 2019.

  16. McKay SL, Guo A, Pergam SA, Dooling K, et al.
    Herpes zoster risk in immunocompromised adults in the United States: A systematic review.
    Clin Infect Dis 2019.

  17. Yamaguchi J, McArthur C, Vallari A, Sthreshley L, et al.
    Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L.
    J Acquir Immune Defic Syndr 2019.

  18. Wise MC, Xu Z, Tello-Ruiz E, Beck C, et al.
    In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity.
    J Clin Invest 2019.

  19. Tymejczyk O, Brazier E, Wools-Kaloustian K, Davies MA, et al.
    Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with HIV in sub-Saharan Africa.
    J Infect Dis 2019.

  20. Zanoni BC, Haberer JE.
    The meaning of "rapid" antiretroviral therapy initiation for adolescents with HIV in sub-Saharan Africa.
    J Infect Dis 2019.

  21. Cunningham CK, McFarland EJ, Morrison RL, Capparelli EV, et al.
    Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
    J Infect Dis 2019.

  22. Gaebler C, Caskey M.
    Broadly neutralizing anti-HIV antibodies in infants: promising new tools for prevention of mother-to-child transmission?
    J Infect Dis 2019.

  23. Prator CA, Thanh C, Kumar S, Pan T, et al.
    Circulating CD30+ CD4+ T Cells Increase Prior to HIV Rebound Following Analytical Antiretroviral Treatment Interruption.
    J Infect Dis 2019.

  24. Huijben S, Macete E, Mombo-Ngoma G, Ramharter M, et al.
    Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
    J Infect Dis 2019.

  25. Wang L, Santella AJ, Wei X, Zhuang G, et al.
    Prevalence and protective factors of HIV and syphilis infection among men who have sex with men in Northwest China.
    J Med Virol 2019.

  26. Henderson LJ, Reoma LB, Kovacs JA, Nath A, et al.
    Advances towards curing HIV-1 infection from tissue reservoirs.
    J Virol 2019.

  27. Registre L, Moreau Y, Toksoz Ataca S, Pulukuri S, et al.
    HIV-1 co-receptor usage and variable loop contact impacts V3 loop bnAb susceptibility.
    J Virol 2019.

  28. Forberg K, Rodgers MA, Dawson GJ, Sauleda S, et al.
    Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.
    Virology 2019;539:69-79.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

11 November 2019

04 November 2019

28 October 2019

21 October 2019

14 October 2019


11 November 2019

Multidisciplinary Journal Club

  1. Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, et al.
    Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med. 2019 Oct 29. doi: 10.1056/NEJMoa1909953.

  2. Martinez L, Cheng W, Wang X, Ling F, et al.
    A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.
    J Infect Dis. 2019 Oct 17. pii: 5589175. doi: 10.1093.

  3. Steichen JM, Lin YC, Havenar-Daughton C, Pecetta S, et al.
    A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
    Science. 2019 Oct 31. pii: science.aax4380. doi: 10.1126/science.aax4380.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016